Access hsTnI is a true high-sensitivity troponin assay that demonstrates <10% CV at the upper reference limits (URL) for men and women and detects troponin in >50% of the healthy population. In an independent study, the assay detected troponin in >99% of healthy men and women. Access hsTnI provides reliable test results that physicians can count on to make faster and more confident decisions about patient management.